SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Send us your Comments

Never Miss a Story

Sign up for email alerts

 

More Industry Headlines

SEC brings charges against Positron Corp. The company is allegedly involved in a market manipulation scheme

PETNET's CEO resigns New CEO brings 12 years of experience

Rising number of U.S. pediatrics receiving proton therapy Treatment yields unique benefits for young cancer patients

Mevion partners with Philips to improve proton therapy treatment New technology only takes a few seconds to scan tumor

Kentucky Trailer acquires Advanced Mobility to expand medical footprint Together they look toward a greater international presence

Screening with tomo and mammo leads to 405 fewer false positives per 1,000 women The cost of the two is relative to cost of mammo alone

Comparing catheters for early stage breast brachytherapy Is the treatment underutilized? The BC5 Project thinks so.

Health Gorilla Marketplace expands in effort to demystify ACO and IPA options Version 2.0 adds seven new vendor categories to its market reach

Siemens' new MR kit may reduce pediatric anxiety and need for sedation Could lead to reduced costs and increased efficiency

400 experts gather at Focused Ultrasound Foundation's annual meeting 200 scientific presentations show promising new research

Price disclosure doesn't
always work, researchers find

Will Mandatory Medical Technology Price Disclosure Actually Increase Prices?

by Barbara Kram , Editor
A new study found that pending congressional legislation seeking the mandatory disclosure of prices for certain medical technologies would likely result in increased prices and "provide no tangible benefits to patients."

The study by Robert W. Hahn, senior fellow at the American Enterprise Institute, and Hal J. Singer, president of Criterion Economics, examines the potential economic impact of the Transparency in Medical Device Pricing Act of 2007 (S. 2221), recently introduced in the U.S. Senate.

Story Continues Below Advertisement

FDA approved successor to the PRISM 3000 XP:

MultiCam 3000eco opens new financial and diagnostic opportunities. Inter Medical of Germany and Eclipse Systems offer the most effective triple-head gamma camera on the market for heart and brain diagnostics.



In the report, the researchers review previous attempts by governments to impose price disclosure rules in a number of other industries including cell phones, groceries, cement, barges, railroads and long-distance telephone services. The authors use evidence from case studies and other sources to identify four conditions that, if satisfied, imply that mandatory price disclosure would provide large benefits to consumers or other purchasers.

"We found that mandatory price disclosure, as proposed in S.2221 is unlikely to benefit patients or hospitals and worse, will likely increase costs," said Hahn.

The authors write that in order for price disclosure to have a favorable effect, there must be large search costs that are reduced substantially, and that the pricing information disclosed be current. The industry-specific market conditions essential for lower prices to occur would require that any savings be passed on to end users, and that there is a large variation in the price paid by purchasers and consumers.

The report finds that the conditions that would likely result in large cost increases as the result of pricing disclosure are met.

Specifically, the report finds that:

* The medical device industry is concentrated among a few firms.
* There are few, if any, economical substitutes for many medical devices.
* Competitors repeatedly interact in the marketplace.
* Some medical devices are standardized whereas other devices are differentiated.
* Firms do not already know their rivals' prices.

The report's findings conclude that:

* Significant search costs for hospitals and patients would remain.
* Disclosure would not provide current price information since the data would be at least three months old.
* The structure of the healthcare industry would not ensure that hospitals pass cost savings on to consumers.

"Applying these conditions to the medical device industry, we conclude that mandatory price disclosure policy would likely increase prices hospitals pay for these products and provide no tangible benefit to patients," said the authors.

The study was supported by the Advanced Medical Technology Association.

More information and the full report are available at: www.criterioneconomics.com.





Related:


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2014 DOTmed.com, Inc.
ALL RIGHTS RESERVED